Schedule 13D ownership disclosure
Bellerophon Therapeutics, Inc.
Security class unavailable · CUSIP: 078771102
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,298,755
- Percent of class
- 12.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001718111-19-000002
- Form type
- SC 13D
- Filer
- Bellerophon Therapeutics, Inc.
- CIK
- CIK 1600132
- Filed
- Jan 29, 2019
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership